Published in: The Business Standard Date: 26 July, 2021 The data provides further support for the decision of several countries to offer alternatives to AstraZeneca […]
Published in: The Daily Star Date: 25 July, 2021 Some patients with past SARS-CoV-2 infections think they have been “naturally immunised” and would not benefit […]
Published in: The Business Standard Date: 23 June, 2021 Dubbed PRINCIPLE, the British study in January showed that antibiotics azithromycin and doxycycline were generally ineffective […]
Published in: The Business Standard Date: 21 June, 2021 The drugmaker said on Monday it analyzed data from 98,654 patients from three retrospective studies of […]
Published in: The Business Standard Date: 21 June, 2021 The drugmakers also said on Monday the US National Institutes of Health (NIH) has recommended sotrovimab […]
Published in: The Daily Star Date: 29 March, 2021 AP, Beijing A joint WHO-China study on the origins of Covid-19 says that transmission of the virus […]
Published in: The Business Standard Date: 28 March, 2021 Most Covid-19 sufferers who lose the ability to taste or smell recover “within three or four […]
Published in: The Daily Star Date: 18 February, 2021 Reuters A laboratory study suggests that the South African variant of the coronavirus may reduce antibody protection […]
Published in: The Business Standard Date: 25 November, 2020 “The therapy know as convalescent plasma did not significantly improve patients’ health status or reduce their […]